Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant.
Urbini B, Arpinati M, Bonifazi F, Chirumbolo G, Falcioni S, Stanzani M, Bandini G, Motta MR, Perrone G, Giannini B, Tura S, Baccarani M, Rondelli D. Urbini B, et al. Among authors: giannini b. Exp Hematol. 2003 Oct;31(10):959-65. doi: 10.1016/s0301-472x(03)00232-7. Exp Hematol. 2003. PMID: 14550812 Free article.
Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML.
Bonifazi F, Bandini G, Rondelli D, Falcioni S, Stanzani M, Bontadini A, Tazzari PL, Arpinati M, Giannini B, Conte R, Baccarani M. Bonifazi F, et al. Among authors: giannini b. Bone Marrow Transplant. 2003 Aug;32(3):237-42. doi: 10.1038/sj.bmt.1704138. Bone Marrow Transplant. 2003. PMID: 12858193 Clinical Trial.
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study.
Bonifazi F, Bandini G, Stanzani M, Palandri F, Giannini B, Arpinati M, Rosti G, Baccarani M. Bonifazi F, et al. Among authors: giannini b. Bone Marrow Transplant. 2005 May;35(10):1025-6. doi: 10.1038/sj.bmt.1704940. Bone Marrow Transplant. 2005. PMID: 15806130 Clinical Trial. No abstract available.
Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely.
Martinelli G, Buonamici S, Visani G, Malagola M, Piccaluga PP, Isidori A, Bosi C, Bonifazi F, Soverini S, Terragna C, Amabile M, Giannini B, Baccarani M. Martinelli G, et al. Among authors: giannini b. Leukemia. 2003 Mar;17(3):650-1; author reply 651-2. doi: 10.1038/sj.leu.2402822. Leukemia. 2003. PMID: 12646962 No abstract available.
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients.
Ghetti M, Vannini I, Bochicchio MT, Azzali I, Ledda L, Marconi G, Melloni M, Fabbri F, Rondoni M, Chicchi R, Angeli D, Ghelli Luserna di Rorà A, Giannini B, Zacheo I, Biguzzi R, Lanza F, Martinelli G, Simonetti G. Ghetti M, et al. Among authors: giannini b. Biomed Pharmacother. 2023 Sep;165:115235. doi: 10.1016/j.biopha.2023.115235. Epub 2023 Aug 1. Biomed Pharmacother. 2023. PMID: 37536029 Free article.
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study.
Marconi G, Candoni A, Di Nicola R, Sartor C, Parisi S, Abbenante M, Nanni J, Cristiano G, Zannoni L, Lazzarotto D, Giannini B, Baldazzi C, Bandini L, Ottaviani E, Testoni N, Bezzi CDG, Abd-Alatif R, Ciotti G, Fanin R, Martinelli G, Paolini S, Ricci P, Cavo M, Papayannidis C, Curti A. Marconi G, et al. Among authors: giannini b. Cancer Med. 2023 May;12(10):11838-11848. doi: 10.1002/cam4.5858. Epub 2023 Mar 31. Cancer Med. 2023. PMID: 36999931 Free PMC article.
40 results